Related Experiment Video

Updated: Aug 20, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

The past, present and future of antiviral drug discovery

Eddy Littler1

  • 1Medivir UK Ltd, Chesterford Research Park, Little Chesterford, Essex, CB10 1XL, UK. eddy.littler@medivir.com

Idrugs : the Investigational Drugs Journal
|December 16, 2004
PubMed

Insights

This review covers antiviral chemotherapy history, current uses, and challenges like viral resistance. Future research focuses on new compounds, emerging viruses, and combination therapies for better treatment outcomes.

Area of Science:

  • Pharmacology
  • Virology
  • Infectious Diseases

Background:

  • Antiviral chemotherapy has evolved significantly since the 1960s.
  • Development faces challenges including viral resistance, safety, and side effects.
  • Current treatments target herpes viruses, HIV, hepatitis, and respiratory viruses.

Purpose of the Study:

  • To provide a comprehensive review of antiviral chemotherapy.
  • To discuss the historical development and current status of antiviral drugs.
  • To identify limitations and future directions in antiviral research.

Main Methods:

  • Literature review of historical and current data on antiviral chemotherapy.
  • Analysis of therapeutic strategies for major viral infections.
  • Assessment of emerging challenges and future research trends.

Main Results:

  • Significant progress has been made in antiviral drug development.
  • Key challenges remain, including drug resistance and adverse effects.
  • Current therapies are available for herpes viruses, HIV, hepatitis, and respiratory viruses.

Conclusions:

  • Antiviral chemotherapy is a critical component of infectious disease management.
  • Future research must address viral resistance and explore novel therapeutic strategies.
  • Combination therapies and preparedness for emerging viruses are crucial for public health.

More Related Videos

Assays for the Identification of Novel Antivirals against Bluetongue Virus12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

Related Concept Videos

Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.